Multiple skin metastases in forearm from base tongue carcinoma  by Rastogi, Madhup et al.
Oral Oncology EXTRA (2005) 41, 188–190http://intl.elsevierhealth.com/journal/ooexCASE REPORTMultiple skin metastases in forearm from
base tongue carcinomaMadhup Rastogi a,*, Kirti Srivastava a, M. Srivastava a, K.S. Chufal b,
M.L.B. Bhatt a, A.N. Srivastava ca Department of Radiotherapy, King George’s Medical University, Chowk, Lucknow 226003, UP, India
b Department of Oncology, Batra Hospital and Medical Research Center, New Delhi 110062, India
c Department of Pathology, King George’s Medical University, Lucknow 226003, UP, IndiaReceived 12 May 2005; accepted 12 May 2005Summary Distant metastases in squamous cell carcinoma of head and neck cancer
(SCCHN) are most often to the lung, liver and bone. SCCHN rarely metastasizes to
skin sites. We encountered a 58-year-old male patient who initially presented with
carcinoma of the base of tongue with T3N2bMO disease and was treated by curative
radiotherapy. After about one and a half years, he developed multiple skin lesions in
the left forearm below the elbow region, which was initially treated for some infec-
tive pathology of skin. But due to no response, cytological examination performed
which turned out to be metastasis from tongue carcinoma. The present case report
describes this rare event along with highlighting some of the important issues which
to be considered under such conditions.c 2005 Elsevier Ltd. All rights reserved.
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dIntroduction
Like most head and neck cancers, carcinomas of
base tongue remain confined to above the clavi-
cles. Besides local spread, neck node metastasis
is the usual mode of spread. About 75–80% patients
with advanced tongue carcinoma have lymph node741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights reser
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dence of distant metastasis is, though, rare, rises
with neck node metastasis. The common sites of
metastasis are lung, liver and bone.2 Skin metasta-
sis (SM) is extremely rare and sometime goes unno-
ticed because of its rare occurrence. SM usually
occurs in the neck, scalp and over the chest wall
that is near to primary site (Fig. 1). We report a
case of carcinoma base of tongue with multiple
skin metastases in the left forearm.ved.
Figure 2 Multiple skin lesions on left forearm below
the left elbow. They are firm, nontender and not fixed to
underlying structures.
Figure 3 (HE, 1000·). Section shows a group of atypical
squamous epithelial cells showing big hyper chromatic
nuclei. There is marked pleomorphism.
Figure 1 Multiple skin metastatic lesions in the neck
and chest wall in a previously irradiated patient of
supraglottic larynx.
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A 58 years old male, chronic smoker, beetle
chewer and alcoholic presented to our OPD in
November 2002 with chief complaints of pain dur-
ing swallowing of 6 months duration and bilateral
neck swellings of 3 months duration. He was well
built but poorly nourished with a Karnofsky Perfor-
mance Score (KPS) of 80. Examination of the oro-
pharynx by direct laryngoscopy revealed an
ulceroproliferative growth involving the right side
of posterior one-third of tongue crossing the mid-
line with extension to the right pharyngeal wall
and vallecula. There were bilateral, hard, discrete,
partially mobile nodes present with normal overly-
ing skin. Biopsy taken from growth showed well-dif-
ferentiated squamous cell carcinoma. All the
baseline investigations including complete hemo-
gram, liver function test, renal function test, X-
ray chest, were well within normal limits. In view
of the above findings patient was diagnosed as a
case of carcinoma base of tongue with T3 N2b MO
(AJC 1997) stage IVA. He was treated with external
radiotherapy with a dose of 70 Gy in 35 fractions in
7 weeks on Cobalt-60 tele therapy machine using
lateral opposing fields to face and neck with con-
current cisplatin based weekly chemotherapy. Pa-
tient tolerated chemo-radiotherapy well and was
advised to attend head and neck cancer clinic reg-
ularly for follow up. He was disease free for about
one and a half years, and in May 2004 he reported
with the complaint of multiple subcutaneous nod-
ules in the left forearm below the elbow region
(Fig. 2). Initially he was given a course of antibioticconsidering some infective pathology of skin, as
there was no sign of recurrence at the local or
nodal site. Despite the antibiotic treatment his skin
nodules kept on increasing in size. Hence fine nee-
dle aspiration cytology performed from the nod-
ules, which revealed a metastatic squamous cell
carcinoma consistent with primary squamous cell
carcinoma of base tongue. As these nodules were
not fixed to underlying structures a wide local exci-
sion was done in the department of surgical oncol-
ogy, which further confirmed the diagnosis (Fig. 3).
Considering the metastatic nature of the disease,
patient was put on cisplatin based palliative che-
motherapy. Patient responded well for 2 months
and later developed headache and another nodule
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2004.Discussion
The frequency of SM from internal malignancies
varies from 0.7% to 9% of all cancer patients.3
The most common sites of distant metastases in
Head and neck cancers are usually lung (70–75%),
liver (17–38%) and bone (23–44%).2 SM has been
reported to occur in 0.8–1.3% of patients with
SCCHN.4 There are very few reports in the litera-
ture about the skin metastasis from head and neck
cancer. Available reports suggest that SM is a rare
event and most common sites of SM were usually
neck, scalp and over the chest wall that is near
to primary site.5,6 Our report highlights the occur-
rence of SM in the left forearm below the elbow,
which is extremely unusual. The exact mechanism
of SM in SCCHN is incompletely understood. There
are three possible mechanisms as outlined by
Kamucha and Troxel,7 namely direct spread, local
spread and distant spread. SM thought to involve
hematogenous spread where pulmonary circulation
and filtration can be theoretically bypassed via the
azygous venous and vertebral venous system via
Batson’s plexus, allowing skin implantation.
Though it is general assumption that SM indicates
poor prognosis for the patient, information is lack-
ing regarding the survival and the proper treatment
of this group of patients. Berger et al.8 in their
study reported that length of survival was approxi-
mately 3 months after skin metastasis become clin-
ically evident in head and neck cancer. The
treatment of SM is inconclusive. Being the meta-
static nature of disease, the treatment of these pa-
tients is, in general, palliative. Options available
are surgical excision, chemotherapy, external
beam radiotherapy, or combination of these. Surgi-
cal excision has been shown to increase survival
time,9 being other forms of treatment are usually
ineffective. Whatever the nature of the primary le-
sion, the course of the disease or the treatment(s)
administered, it appears that skin metastasis is an
equalizing factor for all patient groups in carci-
noma of the head and neck; all patients do poorly
and succumb rapidly to their disease.Conclusion
We report a case of SCCHN, which produced skin
metastases in the left forearm below the left el-
bow, which is extremely rare site. Another issue
which needs emphasis is that a patient with SCCHN
coming for regular follow up when develops such
lesions should be considered with high degree of
suspicion and a confirmatory investigation should
be performed.
Due paucity of data present in the literature,
there are number of question remain unanswered
like prognosis of patients once SM appears, the pri-
mary lesion associated with SM, the type of therapy
to be administered to these patients, the time
interval between the appearance of primary lesion
and to SM, the relationship of the SM to metastases
to other distant sites and the mode of dissemina-
tion resulting in the SM. A larger series are required
to answer these questions as incidence of SCCHN is
increasing nowadays.References
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